Avanir Pharmaceuticals,Incorporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Avanir Pharmaceuticals,Incorporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Avanir Pharmaceuticals,Incorporation Formerly known as AVANIR Pharmaceuticals. The Group's principal activity is to develop, acquire and commercialize novel therapeutic products for the treatment of chronic diseases. The product candidate address therapeutic markets that include the central nervous system and inflammatory diseases. The product candidate Zenvia is in the phase III clinical development for the treatment of pseudobulbar affect and diabetic peripheral neuropathic pain. The Group also has an ongoing development program with Novartis for the treatment of inflammatory disease.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report